HopeStage
Back to all studies
CompletedNCT01663077

Clozapine Blood Levels and Genetic Differences in Schizophrenia

About this titleRead the official source — NCT01663077
Medication studyAges 18–65Israel
The study in practice

Understand this study

Who was this study for?

Listed age limits: 18 years to 65 years.

Listed locations
Tirat CarmelSee all locations and recruitment
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateOctober 2012
Recruitment status
Completed
Enrollment listed in the registry
20
Sponsor
Tirat Carmel Mental Health Center
Sponsor type
Hospital / academic medical center
Study type
Drug
Intervention type
Drug
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Locations
Israel
Age range
From 18 Years to 65 Years
Official registry ID
NCT01663077
Official title
Show the full official title

Clozapine Fixed Dose Steady State Plasma Levels and the Relationship to the Polymorphism of CYP1A2, CYP3A4, CYP3A5 and CYP2D6 in Clinically Stable Schizophrenic Adult Patients

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Tirat Carmel

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Tirat Carmel Mental Health Center, a hospital or academic medical center.

Did this study involve medication?

Yes. The study involved medication, including Clozapine.

Who was this study for?

Listed age limits: 18 years to 65 years.

Want to explore more studies?

Explore studies